Lessons learned from BRCA1 and BRCA2

被引:131
|
作者
Zheng, L [1 ]
Li, S [1 ]
Boyer, TG [1 ]
Lee, WH [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA
基金
美国国家卫生研究院;
关键词
BRCA1; BRCA2; breast cancer; tumor suppressor; transcription regulation; DNA damage repair;
D O I
10.1038/sj.onc.1203968
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are breast cancer susceptibility genes. Mutations within BRCA1 and BRCA1 are responsible for most familial breast cancer cases. Targeted deletion of Brca1 or Brca2 in mice has revealed an essential function for their encoded products, BRCA1 and BRCA2, in cell proliferation during embryogenesis. Mouse models established from conditional expression of mutant Brca1 alleles develop mammary gland tumors, providing compelling evidence that BRCA1 functions as a breast cancer suppressor. Human cancer cells and mouse cells deficient in BRCA1 or BRCA2 exhibit radiation hypersensitivity and chromosomal abnormalities, thus revealing a potential role for both BRCA1 and BRCA2 in the maintenance of genetic stability through participation in the cellular response to DIVA damage. Functional analyses of the BRCA1 and BRCA2 gene products have established their dual participation in transcription regulation and DNA damage repair. Potential insight into the molecular basis for these functions of BRCA1 and BRCA2 has been provided by studies that implicate these two tumor suppressors in both the maintenance of genetic stability and the regulation of cell growth and differentiation.
引用
收藏
页码:6159 / 6175
页数:17
相关论文
共 50 条
  • [41] Genomic rearrangements in the BRCA1 and BRCA2 genes
    Mazoyer, S
    HUMAN MUTATION, 2005, 25 (05) : 415 - 422
  • [42] BRCA1 and BRCA2 alterations in ovarian MMMT
    Geisler, JP
    Goodheart, MJ
    Buller, RE
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 774 - 774
  • [43] Identification of BRCA1 and BRCA2 genetic modifiers
    Weyandt, J. D.
    Snyder, C.
    Lynch, H. T.
    Gillanders, E.
    Holmes, T. N.
    Bailey-Wilson, J.
    Ellsworth, R. E.
    CANCER RESEARCH, 2009, 69 (02) : 117S - 118S
  • [44] A register of known BRCA1 and BRCA2 families
    McAllister, M
    Lalloo, F
    Clancy, T
    Howard, E
    Kerzin-Storrar, L
    Evans, G
    PSYCHO-ONCOLOGY, 2000, 9 (05) : 455 - 455
  • [45] BRCA2 AND BRCA1 breast cancer phenotypes
    Marcus, JN
    Watson, P
    Page, DL
    Narod, SA
    Tonin, P
    Serova, O
    Lenoir, GM
    Lynch, HT
    LABORATORY INVESTIGATION, 1997, 76 (01) : 110 - 110
  • [46] BRCA1 and BRCA2 cancer risks -: Reply
    Chen, Sining
    Iversen, Edwin S., Jr.
    Parmigiani, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (20) : 3313 - 3314
  • [47] Founder mutations in BRCA1 and BRCA2 genes
    Ferla, R.
    Calo, V.
    Cascio, S.
    Rinaldi, G.
    Badalamenti, G.
    Carreca, I.
    Surmacz, E.
    Coliucci, G.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 93 - 98
  • [48] Molecular Trajectory of BRCA1 and BRCA2 Mutations
    Hatano, Yuichiro
    Tamada, Maho
    Matsuo, Mikiko
    Hara, Akira
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] The Brca1 and Brca2 proteins and tumor pathogenesis
    Ingvarsson, S
    ANTICANCER RESEARCH, 1999, 19 (4B) : 2853 - 2861
  • [50] BRCA1 and BRCA2 mutations in women from Shanghai China
    Suter, NM
    Ray, RM
    Hu, YW
    Lin, MG
    Porter, P
    Gao, DL
    Zaucha, RE
    Iwasaki, LM
    Sabacan, LP
    Langlois, MC
    Thomas, DB
    Ostrander, EA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (02) : 181 - 189